Niagen Bioscience, Inc. Cash Flow-to-Debt Ratio
Niagen Bioscience, Inc. cash flow-to-debt ratio. Niagen Bioscience, Inc. (NAGE) has a Cash Flow-to-Debt Ratio of 0.12x as of June 2026, meaning its operating cash flow of $2.77 Million could theoretically repay 0% of its total liabilities ($24.06 Million) in one year. Check how high is Niagen Bioscience, Inc.'s earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Niagen Bioscience, Inc. (2007–2025)
Cash flow-to-debt ratio of Niagen Bioscience, Inc. from 2007 to 2025. Historical debt coverage capacity for Niagen Bioscience, Inc. across 19 annual periods. Check Niagen Bioscience, Inc. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Niagen Bioscience, Inc. Cash Flow-to-Debt Ratio by Year (2007–2025)
Niagen Bioscience, Inc. cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for Niagen Bioscience, Inc.. For the full cash flow conversion analysis, see NAGE cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | $13.44 Million | $29.87 Million | ▼ -17.6% |
| 2024 | 0.55x | $12.11 Million | $22.18 Million | ▲ +103.3% |
| 2023 | 0.27x | $7.12 Million | $26.51 Million | ▲ +145.1% |
| 2022 | -0.59x | $-15.10 Million | $25.39 Million | ▲ +35.7% |
| 2021 | -0.93x | $-24.16 Million | $26.11 Million | ▼ -91.5% |
| 2020 | -0.48x | $-10.60 Million | $21.93 Million | ▲ +53.2% |
| 2019 | -1.03x | $-20.44 Million | $19.80 Million | ▲ +25.7% |
| 2018 | -1.39x | $-20.91 Million | $15.05 Million | ▼ -25.9% |
| 2017 | -1.10x | $-9.80 Million | $8.89 Million | ▼ -267.2% |
| 2016 | -0.30x | $-2.94 Million | $9.78 Million | ▼ -91.7% |
| 2015 | -0.16x | $-2.11 Million | $13.47 Million | ▲ +54.3% |
| 2014 | -0.34x | $-2.58 Million | $7.52 Million | ▲ +70.8% |
| 2013 | -1.18x | $-3.91 Million | $3.32 Million | ▲ +41.4% |
| 2012 | -2.01x | $-10.12 Million | $5.04 Million | ▼ -81.6% |
| 2011 | -1.11x | $-4.10 Million | $3.71 Million | ▲ +34.8% |
| 2010 | -1.69x | $-2.66 Million | $1.57 Million | ▼ -976.5% |
| 2009 | -0.16x | $-396.17K | $2.52 Million | ▲ +80.9% |
| 2008 | -0.82x | $-1.92 Million | $2.33 Million | ▲ +99.1% |
| 2007 | -96.21x | $-38.48K | $400.00 | — |